Case report
Open access
Aug 2026
Bispecific Antibodies Are Associated With Progressive Multifocal Leukoencephalopathy
Background and Objectives Bispecific antibodies (BisAbs) have transformed the management of relapsed and refractory multiple myeloma (MM), achieving high response rates in heavily pretreated patients. However, these therapies induce profound immune perturbation, including plasma cell aplasia, hypogammaglobulinemia, and...
Avi Gadoth, Y. Paran, Yair Mina et al.
· Neurology(R) neuroimmunology... · 0 citations